New Delhi, Oct. 8 -- In a landmark partnership, PGxAI, a leader in AI-powered pharmacogenomics, has joined forces with Najashi Holding, a Riyadh-based healthcare investor, to advance precision medicine in Saudi Arabia. This collaboration supports the Kingdom's Vision 2030, which aims to transform the country's healthcare system and establish Saudi Arabia as a global leader in medical innovation. The primary goal of the partnership is to integrate AI and genomics into Saudi Arabia's healthcare infrastructure to improve patient care, optimize treatment outcomes, and drive the adoption of personalized medicine on a national scale.

PGxAI's platform combines artificial intelligence and genomics to tailor drug selection, reduce adverse reactio...